Pfizer announces positive results for phase-III trial of Etrasimod in Ulcerative Colitis patients
Elevate 12 study met primary and key secondary endpoints of improving clinical remission at week 12
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.